European Heart Journal - Cardiovascular Pharmacotherapy

The European Heart Journal - Cardiovascular Pharmacotherapy (EHJ-CVP) is an international, peer-reviewed journal published in English, specifically dedicated to clinical cardiovascular pharmacology. EHJ-CVP publishes original articles focusing on clinical research involving both new and established drugs and methods, along with meta-analyses and topical reviews. The journal's primary aim is to enhance the pharmacological treatment of patients with cardiovascular disease by interpreting and integrating new scientific developments in this field. While the emphasis is on clinical topics, EHJ-CVP also considers basic research articles from fields such as physiology and molecular biology that contribute to the understanding of cardiovascular drug therapy. These may include articles related to new drug development and evaluation, the physiological and pharmacological basis of drug action, metabolism, drug interactions, and side effects.

European Heart Journal - Cardiovascular Pharmacotherapy (EHJ-CVP)是一本国际同行评审期刊，以英文出版，专注于临床心血管药理学领域。该期刊发表原创文章，侧重于临床研究，涉及新型和已建立的药物和治疗方法，同时也包括荟萃分析和专题评论。其主要目标在于通过解读和整合该领域的新科学进展，加强心血管疾病患者的药物治疗。 尽管重点是临床研究，但EHJ-CVP也欢迎生理学和分子生物学等基础研究领域的投稿，这些研究有助于深入理解心血管药物治疗。期刊欢迎涉及新药开发与评价、药物作用的生理和药理学机制、代谢、药物相互作用以及不良反应等方面的投稿。